Bbs5tm1d(EUCOMM)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Bbs5tm1d(EUCOMM)Wtsi |
| Name: |
Bardet-Biedl syndrome 5; targeted mutation 1d, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:6741143 |
| Synonyms: |
Bbs5delta |
| Gene: |
Bbs5 Location: Chr2:69477515-69497915 bp, + strand Genetic Position: Chr2, 40.91 cM, cytoband C3
|
| Alliance: |
Bbs5tm1d(EUCOMM)Wtsi page
|
| IMPC: |
Bbs5 gene page |
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:307098
|
| Parent Cell Line: |
JM8.N4 (ES Cell)
|
| Strain of Origin: |
C57BL/6N
|
| Project Collection: |
EUCOMM
|
|
| Allele Type: |
|
Targeted (Null/knockout) |
| Mutations: |
|
Insertion, Intragenic deletion
|
| |
|
Mutation details: Cre-mediated recombination of Bbs5tm1c(EUCOMM)Wtsi removed the loxP-flanked exons 4 and 5.
(J:307098)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Bbs5 Mutation: |
17 strains or lines available
|
|
| Original: |
J:307098 Bentley-Ford MR, et al., A mouse model of BBS identifies developmental and homeostatic effects of BBS5 mutation and identifies novel pituitary abnormalities. Hum Mol Genet. 2021 Apr 26;30(3-4):234-246 |
| All: |
1 reference(s) |
|